Health Catalyst, Inc.

HCAT

US42225T1079

Software

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
5.6 ^USD	+0.72%		+1.27%	-39.52%

Apr. 11	North American Morning Briefing : Stock Futures -2-	DJ
Apr. 10	KeyBanc Downgrades Health Catalyst to Sector Weight From Overweight on Potential Risks to Hospital End Markets	MT

Health Catalyst : Farhana Nakhooda COVID-19 Role of Data Interview (Channel News Asia)

December 14, 2020 at 11:45 am EST

Farhana Nakhooda COVID-19 Role of Data Interview (Channel News Asia)

View Interview Here

Channel News Asia | Dec. 11, 2020

Farhana Nakhooda, Senior Vice President, Healthcare & Life Sciences (Asia Pacific), Health Catalyst, interview on Channel News Asia on the role of data in the distribution of COVID-19 vaccinations. The interview runs from time stamp 1:06:58 to 1:13:00…View Interview Here

View Interview Here

Attachments

Original document
Permalink

Disclaimer

Health Catalyst Inc. published this content on 11 December 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 December 2020 16:44:07 UTC

Latest news about Health Catalyst, Inc.

North American Morning Briefing : Stock Futures -2-	Apr. 11	DJ
KeyBanc Downgrades Health Catalyst to Sector Weight From Overweight on Potential Risks to Hospital End Markets	Apr. 10	MT
North American Morning Briefing : Traders Await -2-	Apr. 10	DJ
Transcript : Health Catalyst, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 10:15 AM	Mar. 14
Health Catalyst Shares Rise After CEO Stock Purchase	Feb. 28	MT
Transcript : Health Catalyst, Inc. - Special Call	Feb. 26
KeyBanc Cuts Price Target on Health Catalyst to $10 From $12, Keeps Overweight Rating	Feb. 26	MT
Evercore ISI Adjusts Price Target on Health Catalyst to $10 From $11, Maintains Outperform Rating	Feb. 23	MT
Canaccord Genuity Trims Price Target on Health Catalyst to $11 From $12, Maintains Buy Rating	Feb. 23	MT
Transcript : Health Catalyst, Inc., Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
Earnings Flash (HCAT) HEALTH CATALYST Posts Q4 EPS $0.02, vs. Street Est of $-0.01	Feb. 22	MT
Health Catalyst, Inc. Announces CFO Changes, Effective March 1, 2024	Feb. 22	CI
Health Catalyst, Inc. Announces Board Changes, Effective March 1, 2024	Feb. 22	CI
Health Catalyst, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Earnings Flash (HCAT) HEALTH CATALYST Posts Q4 Revenue $75.1M, vs. Street Est of $73.6M	Feb. 22	MT
Health Catalyst, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024	Feb. 22	CI
Health Catalyst, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
North American Morning Briefing : Cautious Start -2-	Jan. 29	DJ
Guggenheim Upgrades Health Catalyst to Buy From Neutral, Price Target is $14	Jan. 26	MT
Transcript : Health Catalyst, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 01:30 PM	Jan. 10
SacValley Medshare Selects Health Catalyst to Power Its Qualified Health Information Organization	Jan. 08	CI
North American Morning Briefing : S&P 500 Futures -2-	Jan. 04	DJ
Evercore ISI Upgrades Health Catalyst to Outperform From In-Line, Raises Price Target to $11 From $9	Jan. 03	MT
Piper Sandler Adjusts Health Catalyst Price Target to $12 From $11, Maintains Overweight Rating	Dec. 22	MT
North American Morning Briefing : Dow Set For New -2-	Dec. 14	DJ

Chart Health Catalyst, Inc.

Duration

Period

More charts

Company Profile

Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Companyâs solution comprises its cloud-based data and analytics platform, software applications, and professional services expertise. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its clients include academic medical centers, integrated delivery networks, community hospitals, physician practices, health insurers, and others.

Sector

Software

Calendar

2024-05-06 - Q1 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Health Catalyst, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.6 USD

Average target price

12 USD

Spread / Average Target

+114.29%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Application Software

	1st Jan change	Capi.
HEALTH CATALYST, INC.	-39.52%	328M
ADOBE INC.	-20.73%	212B
WORKDAY INC.	-6.97%	67.8B
ROPER TECHNOLOGIES, INC.	-1.02%	57.75B
AUTODESK, INC.	-10.50%	46.62B
DATADOG, INC.	+4.19%	42.26B
ELECTRONIC ARTS INC.	-7.05%	33.99B
ANSYS, INC.	-10.17%	28.46B
APPLOVIN CORPORATION	+78.63%	23.45B
PTC INC.	+3.14%	21.57B

Application Software

Health Catalyst, Inc.

Equities

HCAT

US42225T1079

Software

Health Catalyst : Farhana Nakhooda COVID-19 Role of Data Interview (Channel News Asia)

EPS Revisions